COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
Indivumed partners with University of Rochester Medical Center for patient-centric cancer therapeutics discovery, focusing on precision oncology and advanced stages of solid cancers -
COMMUNIQUÉ DE PRESSE
Bonk, Inc. Provides 2026 Guidance: Forecasts Baseline of 100% Revenue Growth After Capital Restructuring and Asset Repositioning
Bonk, Inc. projects 100% revenue growth in 2026, backed by debt-free balance sheet, $4M Yerbaé contribution, and 51% revenue interest in BONK.fun. Legislative catalysts and strong market indicators reinforce growth strategy -
COMMUNIQUÉ DE PRESSE
Holcim achieves acclaimed CDP “A” rankings for climate and water leadership
Holcim achieves acclaimed 'A' rankings for climate and water leadership, recognized by CDP for transparency and best practices. Carmen Diaz, Chief People and Sustainability Officer at Holcim, emphasizes the company's commitment to sustainability -
-
COMMUNIQUÉ DE PRESSE
SMX's Amended Equity Purchase Agreement: Four Takeaways That Strengthen an Already Transformative Agreement
SMX (NASDAQ:SMX) finalizes amended agreement to strengthen financial foundation, increase strategic flexibility, and support global adoption of molecular marking technology -
-
COMMUNIQUÉ DE PRESSE
CANEX Metals Announces $3 Million Strategic Financing With Eric Fier As Lead Investor and Extends Its Offer to Purchase the Shares of Gold Basin Resources
CANEX Metals Inc. announces C$3 million financing led by Mr. N. Eric Fier to support the acquisition of Gold Basin Resources Corporation and expedited exploration in Arizona. Financing aims to remove financial risk and demonstrate access to capital -
COMMUNIQUÉ DE PRESSE
Fondazione Telethon Announces FDA approval of Waskyra™ (etuvetidigene autotemcel), a Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
Fondazione Telethon announces FDA approval of Waskyra gene therapy for Wiskott-Aldrich Syndrome, offering new hope for patients with rare immunodeficiency. Major achievement in rare disease treatment -
